These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 6176248)
21. Anti-ribosomal P antibodies are associated with elevated circulating IFNα and IL-10 levels in systemic lupus erythematosus patients. Mozo L; López P; Caminal-Montero L; Rodríguez-Carrio J; Suárez A Lupus; 2014 Dec; 23(14):1477-85. PubMed ID: 25107939 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon. Ytterberg SR; Schnitzer TJ Ann Rheum Dis; 1984 Jun; 43(3):457-61. PubMed ID: 6204601 [TBL] [Abstract][Full Text] [Related]
23. [Levels of anti-nDNA using immunofluorescence on Crithidia luciliae. II. Prognostic value of complement-fixing anti-nDNA. Longitudinal study of 16 lupus disorders]. Meyer O; Borda-Iriarte O; Cyna J; Haïm T; Ryckewaert A Rev Rhum Mal Osteoartic; 1984 May; 51(5):243-9. PubMed ID: 6377460 [TBL] [Abstract][Full Text] [Related]
24. Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients. Biswas PS; Aggarwal R; Levesque MC; Maers K; Ramani K Int J Rheum Dis; 2015 Jul; 18(6):646-53. PubMed ID: 25960196 [TBL] [Abstract][Full Text] [Related]
25. Association between IFNA genotype and the risk of systemic lupus erythematosus. Nakashima H; Matsuno S; Akahoshi M; Miyake K; Inoue Y; Tanaka Y; Ninomiya I; Shimizu S; Igawa T; Sadanaga A; Otsuka T; Harada M Clin Rheumatol; 2005 Feb; 24(1):38-40. PubMed ID: 15674657 [TBL] [Abstract][Full Text] [Related]
27. Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus. Nikpour M; Dempsey AA; Urowitz MB; Gladman DD; Barnes DA Ann Rheum Dis; 2008 Aug; 67(8):1069-75. PubMed ID: 18063674 [TBL] [Abstract][Full Text] [Related]
28. Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia. Slavikova M; Schmeisser H; Kontsekova E; Mateicka F; Borecky L; Kontsek P J Interferon Cytokine Res; 2003 Mar; 23(3):143-7. PubMed ID: 12716486 [TBL] [Abstract][Full Text] [Related]
29. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. Vallin H; Perers A; Alm GV; Rönnblom L J Immunol; 1999 Dec; 163(11):6306-13. PubMed ID: 10570325 [TBL] [Abstract][Full Text] [Related]
30. Autoantibodies to HMG-17 nucleosomal protein in autoimmune rheumatic diseases. Correlation with systemic lupus erythematosus clinical activity and with antibodies to double-stranded DNA. Tzioufas AG; Boumba VA; Seferiadis K; Tsolas O; Moutsopoulos HM Arthritis Rheum; 1993 Jul; 36(7):955-61. PubMed ID: 8318042 [TBL] [Abstract][Full Text] [Related]
31. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Bengtsson AA; Sturfelt G; Truedsson L; Blomberg J; Alm G; Vallin H; Rönnblom L Lupus; 2000; 9(9):664-71. PubMed ID: 11199920 [TBL] [Abstract][Full Text] [Related]
32. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830 [TBL] [Abstract][Full Text] [Related]
33. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus. Tydén H; Lood C; Gullstrand B; Jönsen A; Ivars F; Leanderson T; Bengtsson AA Lupus; 2017 Feb; 26(2):139-149. PubMed ID: 27407135 [TBL] [Abstract][Full Text] [Related]
35. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody. Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678 [TBL] [Abstract][Full Text] [Related]
36. MX homologous protein in mononuclear cells from patients with systemic lupus erythematosus. von Wussow P; Jakschies D; Hochkeppel H; Horisberger M; Hartung K; Deicher H Arthritis Rheum; 1989 Jul; 32(7):914-8. PubMed ID: 2751723 [TBL] [Abstract][Full Text] [Related]
37. Systemic and local granzyme B levels are associated with disease activity, kidney damage and interferon signature in systemic lupus erythematosus. Kok HM; van den Hoogen LL; van Roon JAG; Adriaansen EJM; Fritsch-Stork RDE; Nguyen TQ; Goldschmeding R; Radstake TRDJ; Bovenschen N Rheumatology (Oxford); 2017 Dec; 56(12):2129-2134. PubMed ID: 28968826 [TBL] [Abstract][Full Text] [Related]
38. Circulating interferon in human autoimmune diseases. Hooks JJ; Moutsopoulos HM; Notkins AL Tex Rep Biol Med; 1981-1982; 41():164-8. PubMed ID: 6184802 [TBL] [Abstract][Full Text] [Related]
39. Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus. Jin O; Sun LY; Zhou KX; Zhang XS; Feng XB; Mok MY; Lau CS Clin Rheumatol; 2005 Apr; 24(2):107-10. PubMed ID: 15818511 [TBL] [Abstract][Full Text] [Related]
40. Interferon alpha gene expression and serum level association with low vitamin D levels in Egyptian female patients with systemic lupus erythematosus. Abdel Galil SM; El-Shafey AM; Abdul-Maksoud RS; El-Boshy M Lupus; 2018 Feb; 27(2):199-209. PubMed ID: 28659049 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]